PML targeting eradicates quiescent leukaemia-initiating cells Journal Article


Authors: Ito, K.; Bernardi, R.; Morotti, A.; Matsuoka, S.; Saglio, G.; Ikeda, Y.; Rosenblatt, J.; Avigan, D. E.; Teruya-Feldstein, J.; Pandolfi, P. P.
Article Title: PML targeting eradicates quiescent leukaemia-initiating cells
Abstract: The existence of a small population of 'cancer-initiating cells' responsible for tumour maintenance has been firmly demonstrated in leukaemia. This concept is currently being tested in solid tumours. Leukaemia-initiating cells, particularly those that are in a quiescent state, are thought to be resistant to chemotherapy and targeted therapies, resulting in disease relapse. Chronic myeloid leukaemia is a paradigmatic haematopoietic stem cell disease in which the leukaemia-initiating-cell pool is not eradicated by current therapy, leading to disease relapse on drug discontinuation. Here we define the critical role of the promyelocytic leukaemia protein (PML) tumour suppressor in haematopoietic stem cell maintenance, and present a new therapeutic approach for targeting quiescent leukaemia-initiating cells and possibly cancer-initiating cells by pharmacological inhibition of PML. ©2008 Macmillan Publishers Limited. All rights reserved.
Keywords: adult; controlled study; human tissue; protein expression; nonhuman; protein function; animal cell; mouse; cytology; animals; mice; protein targeting; cell line; animal experiment; recurrence; mice, inbred c57bl; transcription factors; nuclear proteins; regeneration; cancer inhibition; arsenicals; oxides; gene expression regulation, neoplastic; neoplastic stem cells; leukemia cell; tumor suppressor proteins; hematopoietic stem cells; hematopoietic stem cell; tumor; leukemia, myelogenous, chronic, bcr-abl positive; disease treatment; coculture techniques; promyelocytic leukemia protein; drug; blood system disorder
Journal Title: Nature
Volume: 453
Issue: 7198
ISSN: 0028-0836
Publisher: Nature Publishing Group  
Date Published: 2008-05-19
Start Page: 1072
End Page: 1078
Language: English
DOI: 10.1038/nature07016
PUBMED: 18469801
PROVIDER: scopus
PMCID: PMC2712082
DOI/URL:
Notes: --- - "Cited By (since 1996): 129" - "Export Date: 17 November 2011" - "CODEN: NATUA" - "Source: Scopus"
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Julie T Feldstein
    297 Feldstein
  2. Keisuke Ito
    4 Ito